DexCom vs West Pharmaceutical Services

DexCom (DXCM), health care, and West Pharmaceutical Services (WST), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

DexCom is worth $30.6B on the stock market and West Pharmaceutical Services $28.8B: DexCom is valued at 6% more. DexCom trades at 32.3 times earnings and West Pharmaceutical Services at 46.5; operating margins in their latest fiscal years were 19.6% and 19.0%. Over the past year DexCom's share price has moved +35.6% and West Pharmaceutical Services's +60.6%.

Key facts

DexCom market value
$30.6B
West Pharmaceutical Services market value
$28.8B
DexCom P/E
32.3
West Pharmaceutical Services P/E
46.5
DexCom revenue
$4.7BFY to 2025-12-31
West Pharmaceutical Services revenue
$3.1BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

DexCom vs West Pharmaceutical Services: every measure side by side
Measure DexCom West Pharmaceutical Services
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$30.6Bhigher$28.8Blower
Revenue$4.7Bhigher$3.1Blower
Earnings$836.3Mhigher$493.7Mlower
Employees11,000higher10,000lower
Total assets$6.3Bhigher$4.3Blower
Valuation
P/E32.3lower46.5higher
P/S6.6lower9.4higher
P/B12.1higher9.7lower
Dividend yield0.00%lower0.21%higher
Profitability
Operating margin19.6%higher19.0%lower
Balance sheet
Net assets$2.7Blower$3.2Bhigher
Total liabilities$3.6Bhigher$1.1Blower
Total debt—$202.8M
Cash on hand$917.7Mhigher$791.3Mlower
Price change
Today+0.53%higher-0.88%lower
1 year+35.6%lower+60.6%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

West Pharmaceutical Services only (3)

Percentages are each holding's share of that investor's reported portfolio. Who owns DXCM · Who owns WST

Further comparisons

Learn

Questions and answers

Which is bigger, DexCom or West Pharmaceutical Services?

By market value, DexCom is the larger: $30.6B against $28.8B for West Pharmaceutical Services. By revenue in its latest fiscal year, DexCom is the larger: $4.7B against $3.1B for West Pharmaceutical Services.

Which has the higher P/E ratio?

West Pharmaceutical Services: 46.5, against 32.3 for DexCom. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

DexCom: 19.6%, against 19.0% for West Pharmaceutical Services. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

West Pharmaceutical Services: 0.21%, against 0.00% for DexCom. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both DexCom and West Pharmaceutical Services?

None of the tracked superinvestors holds both in their latest 13F filing. 2 hold DexCom and 3 hold West Pharmaceutical Services.

Cite this page

Funkfolio, “DexCom vs West Pharmaceutical Services”, data as of 18 November 2026. https://funkfolio.com/compare/dxcm-vs-wst

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.